Sign Up to like & get recommendations! 0
Published in 2019 at "Neurourology and Urodynamics"
DOI: 10.1002/nau.24139
Abstract: To investigate the mechanism of bladder nerve hyperplasia and fibrosis in the patients with ketamine‐associated cystitis (KC). read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Pediatric Pulmonology"
DOI: 10.1002/ppul.23763
Abstract: Cystic Fibrosis (CF) patients frequently use aminoglycosides (AGS) to treat CF exacerbation due to colonization with Pseudomonas aeruginosa. Although AGS can cause vestibular and auditory sensory losses that can negatively impact quality of life, little… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Pediatric Pulmonology"
DOI: 10.1002/ppul.25569
Abstract: The primary objective of this study was to compare the therapeutic predictive value of area under the curve (AUC24) versus maximum concentration (Cmax) in cystic fibrosis (CF) patients receiving intravenous (IV) tobramycin for a Pseudomonas… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Pediatric Pulmonology"
DOI: 10.1002/ppul.25946
Abstract: This pilot study successfully implemented a standardized protocol for tablet‐based ototoxicity screening in pediatric cystic fibrosis (CF) patients exposed to aminoglycosides. Further studies are needed to assess the impact of implementation in a larger number… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Rheumatology International"
DOI: 10.1007/s00296-021-04804-8
Abstract: Only limited data are available on the risk of liver fibrosis in patients with rheumatoid arthritis on long-term methotrexate treatment. To assess the risk of liver fibrosis in patients with rheumatoid arthritis treated with methotrexate,… read more here.
Sign Up to like & get recommendations! 1
Published in 2021 at "Journal of Gastroenterology"
DOI: 10.1007/s00535-021-01782-3
Abstract: The usefulness of APRI or FIB-4 is well established as a non-invasive liver fibrosis marker at a point of diagnosis in patients with chronic liver disease. However, their applicability for the monitoring of progression of… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "International journal of antimicrobial agents"
DOI: 10.1016/j.ijantimicag.2018.05.008
Abstract: Pseudomonas aeruginosa is responsible for chronic respiratory tract colonisation and acute exacerbations in cystic fibrosis (CF) patients. This Gram-negative bacterium often develops multidrug resistance, which represents a therapeutic challenge. The objective of this study was… read more here.
Sign Up to like & get recommendations! 1
Published in 2020 at "Saudi Journal of Biological Sciences"
DOI: 10.1016/j.sjbs.2020.05.041
Abstract: Background Previous reports have shown that pulmonary and systemic hypergamma-globulinemia in CF patients is a reflection of chronic pulmonary infection. Infection with Pseudomonas aeruginosa is known to have major prognostic significance in patients CF. This… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Journal of medicinal chemistry"
DOI: 10.1021/acs.jmedchem.1c01684
Abstract: Pseudomonas aeruginosa is of major concern for cystic fibrosis patients where this infection can be fatal. With the emergence of drug-resistant strains, there is an urgent need to develop novel antibiotics against P. aeruginosa. MurB… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Journal of Medicinal Chemistry"
DOI: 10.1021/acs.jmedchem.2c00270
Abstract: Lung infection is the leading cause of morbidity and mortality in cystic fibrosis (CF) patients and is mainly dominated by Pseudomonas aeruginosa. Treatment of CF-associated lung infections is problematic because the drugs are vulnerable to… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Hematology"
DOI: 10.1080/10245332.2018.1540518
Abstract: ABSTRACT Objectives: This study aimed to estimate the prevalence of liver fibrosis and assess the risk factors for developing significant liver fibrosis in patients with Thalassemia Major (TM). Methods: All patients with TM over the… read more here.